Deal History

Acted as advisor to Lyondell in the acquisition of PDVSA's 41.25% stake in Lyondell for $2.2 billion.

Completed seed round and second round of financing via private placement of equity for Insignis Therapeutics, producer of an EpiPen alternative for treatment of anaphylaxis.

Acted as advisor to SilverMill in its acquisition of Cedarlane Laboratories.

Acted as advisor to Genzyme Corporation in the sale of its Genzyme Pharmaceutical Ingredients Business in Switzerland to International Chemical Investors Group (ICIG).

Acted as advisor to Caliper Life Sciences, the leading microfluidics company, in its acquisition of NovaScreen, a life science services company.

Co-managed the $87 million IPO of Chirex, a pharmaceutical and intermediates company.

Acted as advisor to Apollo in its acquisition of Taminco from CVC Capital Partners for $1.5 billion.

Acted as advisor to Shell Chemicals in the sale of its Global Resins and Versatics business to Apollo Management for $860 million.

Bookrunner for $760 million IPO of CF Industries.

Acted as advisor to KKR in the sale of Borden Chemical to Apollo Management for $1.2 billion.

Global Coordinator on $4.2 billion bank and high yield financing for the LBO of Celanese by Blackstone.

Acted as advisor to Dow Chemical in the sale of its 50% stake in UOP LLC to Honeywell.

Acted as advisor to Crompton in the $2.5 billion acquisition of Great Lakes Chemical to form Chemtura.

Bookrunner for $1.04 billion IPO of Celanese Corporation.

Acted as advisor to Ripplewood Holdings in the sale of Kraton Polymers to Texas Pacific Group for $770 million.

Acted as advisor to BF Goodrich in the sale of its chemicals division (Noveon) to AEA Investors for $1.4 billion.

Acted as advisor to Great Lakes in the sale of its oilfield services business OSCA to BJ Services for $440 million.

Acted as advisor to Castle Harlan in its sale of INDSPEC to Occidental Petroleum for $300 million.

Acted as advisor to Shell Chemicals in the sale of its KRATON Polymers business to Ripplewood for $560 million.

Acted as advisor to Mitsubishi in its sale of Aristech Chemicals to Sunoco for $860 million.

Acted as advisor to Uniroyal Chemical in its $1.4 billion merger with Crompton & Knowles Corp.